The performance of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the loss of exclusivity in key territories has introduced substantial volatility. Investors are now grappling with the effect of lowe